Breast cancer drug boosts survival by 52 per cent in young women, study claims – The Sun

0
12
Breast cancer drug boosts survival by 52 per cent in young women, study claims – The Sun



A NEW drug boosts survival by more than half in younger women with incurable breast cancer, research shows.
Campaigners are hailing ribociclib as “one of the most important advances for decades”.
2 Breast cancer drug which blocks proteins that feed tumour growth has been proven to boost survival in pre-menopausal womenCredit: Getty
Up to 1,500 pre-menopausal women a year could benefit from taking it — but only around half currently get it on the NHS.
The trials show the daily tablets keep the disease at bay for 11 months longer than standard treatments for advanced cancer.
It means patients can delay having chemotherapy.
The American Society of Clinical Oncology’s conference in Chicago was told that ribociclib works by blocking proteins that feed tumour growth.
Researchers at the University of California found that after 3½ years, patients on the drug had a 70 per cent chance of being alive.
It compared to 46 per cent for those on standard treatment alone — a survival difference of 52 per cent.
Graphic WarningTHE ‘CURSED’ CHILD A MUM WON’T LOVE Heartbreaking photos show the premature baby whose mum won’t hold or feed her Sex Secrets Prostitute who earns £2,000 a week reveals the average penis size … and how much she enjoys work HAPPY ST PADDY’S DAY Guinness IS good for you – and here’s six surprising reasons why PASSION PEAKS This is the age when your sex drive will be at its most rampant (and girls, it might surprise you) CHIN UP The truth about YOUR double chin, what’s really causing it – and the DAFT exercises that can help banish it Home remedies What causes mouth ulcers and how to treat them with stuff you have at home
A total of 672 women below 59 who had advanced breast cancer took part.
Lead researcher Dr Sara Hurvitz said: “It is good news for women with this terrible disease.”
Baroness Delyth Morgan, at Breast Cancer Care and Breast Cancer Now, said: “The way it slows cancer growth represents one of the greatest advances in breast cancer research in recent decades.”
2 Trials of ribociclib show the daily tablets keep the disease at bay for 11 months longer than standard treatments for advanced cancerCredit: Getty
CoppaFeel’s boob check video reveals how you can identify deadly breast cancer signs on the body

LEAVE A REPLY

Please enter your comment!
Please enter your name here